Related Experiment Videos
Decrease in the rate of protein synthesis by polysomes from cultured fibroblasts of patients and carriers with
Abstract:
Polysomes extracted from cultured fibroblast cells isolated from patients with Duchenne muscular dystrophy (DMD), carriers of the disease, and normal controls were used for in vitro measurement of protein synthesis in a wheat germ extract system. It was observed that polysomes from patients and carriers (seven of each aged 17 years or older) exhibited a 3-fold and a 1.5-fold decrease in the rate of protein synthesis, respectively, as compared with controls. These results are discussed with a view to developing a sensitive and easily available assay for the detection of DMD carriers.
Insights
Polysomes from Duchenne muscular dystrophy (DMD) patients and carriers show significantly reduced protein synthesis rates. This finding suggests a potential new assay for detecting DMD carriers.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
- Identifying carriers is crucial for genetic counseling and reproductive planning.
- Current carrier detection methods may have limitations.
Purpose of the Study:
- To investigate protein synthesis rates in polysomes from DMD patients and carriers.
- To explore the potential of polysome function as a biomarker for DMD carrier detection.
Main Methods:
- Polysomes were extracted from cultured fibroblast cells of DMD patients, carriers, and normal controls.
- In vitro protein synthesis rates were measured using a wheat germ extract system.
- Analysis focused on individuals aged 17 years and older.
Main Results:
- Polysomes from DMD patients showed a 3-fold decrease in protein synthesis rate compared to controls.
- Polysomes from DMD carriers exhibited a 1.5-fold decrease in protein synthesis rate.
- A notable reduction in protein synthesis was observed in both patients and carriers.
Conclusions:
- Reduced polysomal protein synthesis is a characteristic feature in individuals with Duchenne muscular dystrophy.
- This functional assay shows promise for developing a sensitive and accessible method for detecting DMD carriers.
- Further research can validate this approach for clinical application in genetic diagnostics.